Genesis Capital, a Chinese GP established by Richard Peng, who previously led investments for Tencent Holdings, has closed its second US dollar-denominated fund at the hard cap of $850 million.
Peng founded the business in 2015 with Kurt Xu, who held senior positions at Tencent across operations, strategy, and investment. The GP raised approximately $450 million for its debut vehicle in 2016...
Increased climate change awareness on a corporate level is leading to more investment – either direct or through funds – in start-ups that offer mitigation solutions. Asia is a key geography
Healthcare-focused Panacea Venture has led a $40 million Series C round for China’s XWPharma, a neurobiology-focused biotech developer previously known as XW Laboratories.
Kyee Technology, a Chinese digital medical platform has raised RMB430 million ($64 million) in a Series D round led by Tencent Holdings. Other investors include Longmen Capital, Dyee Capital and Royal Sea Capital.
Biocytogen, a Chinese contract research organization (CRO) that provides genetically-modified mice for drug testing, has raised RMB970 million ($143 million) in an extended tranche of Series D funding.